CURE Media Group and the Sarcoma Foundation of America have teamed up to battle soft tissue cancer through CURE Media Group's Advocacy Spotlight Partnership program.
PLAINSBORO, N.J. (July 9, 2015) — CURE Media Group and the Sarcoma Foundation of America have teamed up to battle soft tissue cancer through CURE Media Group’s Advocacy Spotlight Partnership program. CURE Media Group, whose flagship product CURE® magazine is the largest cancer-focused consumer publication in the country, and the Foundation today announced their alliance to fight this rare cancer that primarily affects young people.
“During Sarcoma Awareness Month, we are especially proud to announce this alliance with the Sarcoma Foundation of America which will enable us to more effectively share information about sarcoma, cancer that arises from cells that hold the body together,” said Mike Hennessy Jr., president of Intellisphere Oncology and Healthcare Specialty Group, part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses. “CURE’s editorial and marketing teams will work with the Sarcoma Foundation to highlight basic information about sarcomas, as well as research breakthroughs and treatment options.”
“Sarcoma is a cancer of connective tissues, such as nerves, muscles, joints, fat, bones and blood vessels, and it can arise anywhere in the body,” said Bert E. Thomas IV, Ph.D., CEO of the Sarcoma Foundation, which is based in Damascus, Md. “The disease is rare, and in fact many sarcoma patients have never heard of anyone else with their cancer. They — and their healthcare providers – may not know all of the treatment options, or that nonprofits can help.
“That’s why our partnership with CURE Media Group is so important,” Thomas continued, pointing out that sarcoma is often misdiagnosed and underreported. “Together, we can help educate people about sarcomas, which can arise anywhere, with the most frequent locations being the limbs, where the majority of the body’s connective tissue resides. Sarcomas are commonly hidden deep in the body, so the disease is often diagnosed at a later stage with a larger tumor, complicating treatment and compromising outcomes. Although a lot of the lumps and bumps we get are benign, people should have them looked at by a doctor at an early stage in case they are sarcoma.”
While sarcoma is sometimes curable by surgery, chemotherapy and/or radiation, about half the time sarcomas are totally resistant to all these approaches — hence the extreme need for new therapeutic approaches, Thomas noted. At any one time, about 50,000 patients and their families are struggling with sarcoma. Each year, approximately 15,000 new cases are diagnosed and nearly 6,000 people die from the disease.
“CURE Media Group, through its unique and award-winning digital and print products, will work with the Sarcoma Foundation to share information about these rare diseases and publicize the Foundation’s efforts to raise funds and promote research,” Hennessy said.
About CURE magazine and CURE Media Group
CURE Media Group’s flagship product, CURE magazine, is the indispensable guide to every stage of the cancer experience. With nearly 1 million readers, CURE is the largest consumer publication in the United States focused entirely on cancer, with broad distribution to cancer patients, cancer centers and advocacy groups. Through the magazine, live meetings, a resource guide for the newly diagnosed, the Extraordinary Healer™ national nursing award, and other books and online tools, CURE Media Group combines science and humanity to make cancer understandable. CURE Media Group is part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses, which includes the acclaimed OncLive (www.onclive.com) platform of resources for the practicing oncologist. For more information, visit www.curetoday.com or www.mjhassoc.com.
About the Sarcoma Foundation of America
The Sarcoma Foundation of America (SFA), a 501(c)(3) nonprofit charitable organization, is an advocate for increased research to find new and better therapies with which to treat patients with sarcoma. The organization raises money to privately fund grants for sarcoma researchers and conducts education and advocacy efforts on behalf of sarcoma patients. For more information, please visit www.curesarcoma.org.
For Sarcoma Foundation of America: Lori Hoffman, 301-253-8687, firstname.lastname@example.org
For CURE: Becky Taylor, 609-240-6886, email@example.com